SOPH - Sophia Genetics SA
Sophia Genetics SA Logo

SOPH - Sophia Genetics SA

https://www.sophiagenetics.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes - Sophia Genetics ( NASDAQ:SOPH ) , AstraZeneca ( NASDAQ:AZN )
Benzinga • 1 month, 1 week ago • score: 0.22
BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS SOPH, a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca AZN. This new, multi-year collaboration will leverage ...
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$4.92
52W Low
$2.58
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.02
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.30
EV/Revenue (<3 favorable)
2.70
P/S (TTM) (<3 favorable)
3.14
P/B (<3 favorable)
2.86
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
6.46%
Institutions (25–75% balanced)
48.20%
Shares Outstanding
67,580,000
Float
50,710,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
69,688,000
Gross Profit (TTM)
47,234,000
EPS (TTM)
-1.10
Profit Margin (>10% good)
-1.05%
Operating Margin (TTM) (higher better)
-1.01%
ROE (TTM) (>15% strong)
-0.74%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.16
Momentum
Bearish momentum
Value
-0.0455
Previous
-0.0268
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025